Sonnet Biotherapeutics Holdings Inc. buy Chardan Capital
Start price
28.05.24
/
50%
€0.18
Target price
28.05.25
€27.57
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 28.05.25. The prediction end date can be changed by Chardan_Capital at any time.Performance without dividends (%)
Name | 1w | 1m |
---|---|---|
Sonnet Biotherapeutics Holdings Inc. | - | - |
iShares Core DAX® | -0.372% | 5.236% |
iShares Nasdaq 100 | -1.950% | 1.680% |
iShares Nikkei 225® | -1.690% | 7.286% |
iShares S&P 500 | -0.399% | 2.379% |
Comments by Chardan_Capital for this prediction
In the thread Sonnet Biotherapeutics Hldgs. Inc. diskutieren
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $30.00 price target on the stock.
Ratings data for SONN provided by MarketBeat
Stopped prediction by Chardan_Capital for Sonnet Biotherapeutics Holdings Inc.
Sonnet Biotherapeutics Holdings Inc.
Start price
Target price
Perf. (%)
€0.18
23.08.24
23.08.24
€26.85
23.08.25
23.08.25
-
20.11.23
20.11.23
Sonnet Biotherapeutics Holdings Inc.
Start price
Target price
Perf. (%)
€0.18
15.02.24
15.02.24
€27.86
15.02.25
15.02.25
-
20.11.23
20.11.23
Sonnet Biotherapeutics Holdings Inc.
Start price
Target price
Perf. (%)
€0.38
16.08.23
16.08.23
€11.00
16.08.24
16.08.24
-51.06%
17.08.24
17.08.24